Struggling to find Novolog at your pharmacy? Learn why this rapid-acting insulin is hard to find in 2026 and what steps you can take right now.
If you've recently walked into your pharmacy only to be told that Novolog is out of stock, you're not alone. Thousands of people with diabetes across the United States have been dealing with the same frustrating experience. Whether you have type 1 or type 2 diabetes, running low on your mealtime insulin can feel overwhelming — and even dangerous.
In this article, we'll break down exactly what's going on with Novolog availability in 2026, why it's been so difficult to find, and what you can do to get your prescription filled.
Novolog is the brand name for Insulin Aspart, a rapid-acting insulin analog made by Novo Nordisk. It's used by millions of Americans with type 1 and type 2 diabetes to control blood sugar spikes at mealtimes. You inject it 5 to 10 minutes before eating, and it starts working within about 15 minutes.
Novolog comes in several forms, including 10 mL vials, FlexPen prefilled pens, and FlexTouch pens. It's one of the most commonly prescribed rapid-acting insulins in the country, which is part of why supply problems affect so many people.
To learn more about this medication, check out our guide on What Is Novolog: Uses, Dosage, and What You Need to Know.
There are several reasons why Novolog has been difficult to locate at pharmacies. Here are the main factors:
Novolog experienced significant supply disruptions starting in 2024. Novo Nordisk confirmed backorders that affected vial presentations most severely. While the company resumed shipping in mid-2024, demand continued to outpace supply for months. Heading into 2026, some pharmacies — especially large chain pharmacies — still experience periodic stock-outs.
One of the biggest changes came at the end of 2025 when Novo Nordisk discontinued its unbranded biologic Insulin Aspart. This was a more affordable, generic-like version of Novolog that many patients and pharmacies relied on. With that option gone, more patients shifted back to brand-name Novolog, increasing demand on an already strained supply.
The number of Americans diagnosed with diabetes continues to grow. According to the CDC, over 38 million Americans have diabetes, and millions more are diagnosed each year. As the patient population grows, so does the demand for essential insulins like Novolog.
Large chain pharmacies typically order insulin based on projected demand. When supply is uncertain, pharmacies may not stock as much Novolog as usual, leading to more frequent out-of-stock situations. Independent pharmacies sometimes have more flexibility in sourcing from different wholesalers, which can help.
If your pharmacy doesn't have Novolog in stock, don't panic. Here are several steps you can take:
Medfinder lets you search for pharmacies near you that have Novolog in stock right now. Instead of calling pharmacy after pharmacy, you can check availability online and save time — especially when every hour matters.
Independent and compounding pharmacies often have access to different wholesale distributors than large chains. They may have Novolog in stock when your usual pharmacy doesn't. For more tips, read our guide on How to Find Novolog in Stock Near You.
If Novolog is consistently unavailable, your prescriber can switch you to another rapid-acting insulin. Options include Humalog (Insulin Lispro), Fiasp, Admelog, or Apidra (Insulin Glulisine). These work similarly to Novolog and may be easier to find. Learn more in our post on Alternatives to Novolog.
Novo Nordisk's NovoCare program can help you locate pharmacies with stock and connect you with savings programs. Call 1-866-310-7549 or visit NovoCare.com.
If you're able to, work with your prescriber to maintain a small buffer supply of Novolog. Some insurance plans allow early refills for maintenance medications, especially when shortages are documented. Talk to your pharmacy and insurance company about options.
Without insurance, Novolog can cost between $130 and $350 per vial or pen pack, depending on the pharmacy and quantity. With the Novo Nordisk savings card, commercially insured patients can pay as little as $35 per 30-day supply. Medicare Part D patients are also capped at $35 per month for covered insulin products.
For a deep dive on savings strategies, check out How to Save Money on Novolog in 2026.
Finding Novolog in 2026 can be a challenge, but it's not impossible. Supply chain issues, the discontinuation of unbranded Insulin Aspart, and growing demand have all contributed to the problem. The most important thing is to plan ahead, explore your options, and use tools like Medfinder to locate pharmacies with stock near you.
If you're struggling to fill your prescription, talk to your doctor about alternatives, reach out to NovoCare for assistance, and never skip doses without medical guidance. Your health depends on it.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
